2025): Advanced Pharmacology Fundamentals -
Chamberlain
Schedule drugs APRNs can prescribe - ANSWER Drugs that APRNs have the
authority to prescribe
Determiner and regulator of prescriptive authority - ANSWER Entity responsible for
determining and regulating prescriptive authority
Impact of limited prescriptive authority on patients - ANSWER Effects of limited
prescriptive authority on patients within the healthcare system
Key responsibilities of prescribing - ANSWER Primary duties and obligations of
prescribing medications
Factors used to make prescribing decisions - ANSWER Criteria or considerations
used to make decisions about prescribing medications
Pharmacokinetic changes in older adults - ANSWER Changes in drug absorption,
distribution, metabolism, and excretion in older adults
Pharmacodynamic changes in older adults - ANSWER Changes in drug effects and
responses in older adults
Beer's Criteria - ANSWER Guidelines for potentially inappropriate medication use in
older adults
Importance of Beer's Criteria - ANSWER Significance and relevance of Beer's
Criteria in clinical practice
Impacts/outcomes of polypharmacy - ANSWER Effects and consequences of taking
multiple medications concurrently
CYP450 inhibitors - ANSWER Substances that inhibit the activity of cytochrome
P450 enzymes
Examples of CYP450 inhibitors - ANSWER Specific drugs or substances that inhibit
cytochrome P450 enzymes
Consequences of incorrect use of CYP450 inhibitors - ANSWER Adverse effects or
outcomes resulting from improper use of CYP450 inhibitors
CYP450 inducers - ANSWER Substances that induce the activity of cytochrome
P450 enzymes
, Examples of CYP450 inducers - ANSWER Specific drugs or substances that induce
cytochrome P450 enzymes
Consequences of incorrect use of CYP450 inducers - ANSWER Adverse effects or
outcomes resulting from improper use of CYP450 inducers
Poor metabolism phenotype - ANSWER Genetic or physiological condition resulting
in impaired drug metabolism
Regulation of medications by the U.S. FDA - ANSWER Aspects of medications
regulated by the U.S. Food and Drug Administration
Reasons for medication non-adherence - ANSWER Factors or causes contributing to
patients not adhering to medication regimens
Black Box Warnings - ANSWER Strongest warning labels issued by the U.S. FDA for
prescription drugs
Definition and importance of neonate and infant drug absorption - ANSWER Process
and significance of drug absorption in neonates and infants
General development and absorption in neonates and infants - ANSWER Stages
and timeline of development and absorption of drugs in neonates and infants
Common fears with genetic testing - ANSWER Typical concerns or anxieties
associated with genetic testing
Guiding principles for prescribers - ANSWER Fundamental principles or guidelines
for healthcare providers when prescribing medications
Examples of pure opioid agonists - ANSWER Specific drugs that act as pure opioid
agonists
Calculation of patient's overdose risk - ANSWER Process of determining the
likelihood of a patient experiencing an overdose
Referral to pain specialist for pain management - ANSWER When and why to refer a
patient to a pain specialist for managing pain
Prescription Drug Monitoring Program (PDMP) - ANSWER Database or system used
to monitor the prescribing and dispensing of controlled substances
Importance of Prescription Drug Monitoring Program (PDMP) - ANSWER
Significance and benefits of utilizing the Prescription Drug Monitoring Program
Impact of renal and hepatic function on medication levels - ANSWER How kidney
and liver function affect the levels of medications in the body
Assessment for possible drug diversion - ANSWER Process of evaluating and
identifying potential drug diversion in patients